(Q45565740)

14 December 2017

Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae (English)

1 reference

14 December 2017

carbapenem antibiotic

0 references

0 references

1

David M Livermore

1 reference

14 December 2017

Shazad Mushtaq

2

1 reference

PubMed ID

23580564

14 December 2017

language of work or name

English

0 references

publication date

10 April 2013

1 reference

Journal of Antimicrobial Chemotherapy

14 December 2017

1 reference

14 December 2017

68

1 reference

14 December 2017

1825-1831

1 reference

14 December 2017

8

1 reference

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

14 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

The inhibition of class C beta-lactamases by boronic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Therapeutic potential of boron-containing compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Alterations of susceptibility of Pseudomonas aeruginosa by overproduction of multidrug efflux systems, MexAB-OprM, MexCD-OprJ, and MexXY/OprM to carbapenems: substrate specificities of the efflux systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT118

21 January 2018

Identifiers

DOI

10.1093/JAC/DKT118

1 reference

14 December 2017

1 reference

PubMed ID

23580564